Latest research reveals that UK football fans are increasingly uneasy about fossil fuel investment into their favourite clubs
Friday 28 March, 2025 Half of football fans uneasy about fossil fuel…
Sparian Biosciences Announces Results from the Phase 1 Clinical Trial of First in Class Novel Arylepoxamide Receptor (AEAr) Agonist Analgesic SBS-1000
SBS-1000 was shown to be safe and well tolerated in healthy volunteers…
